Zhong Guo Ji Jin Bao·2025-07-05 04:46Group 1 - Notable fund manager Wan Minyuan increased holdings in Dongfang Biological, holding 5 million shares, representing 2.48% of the company, ranking as the fifth largest shareholder [3] - Dongfang Biological has been consistently favored by Wan Minyuan's fund since Q2 2024, with an increase of 778,300 shares compared to Q1 2024 [3] - Dongfang Biological specializes in the research, production, and sales of in vitro diagnostic products and has over 50 subsidiaries globally [3] Group 2 - Fund managers Yan Siqian and Lü Yuechao reduced their stakes in Qin'an Co., with new entries in the top ten shareholders, including Liu Xiaofei's fund [6] - Qin'an Co. has seen its stock price double this year, with a significant acquisition of 99% of Anhui Yigao Optoelectronics [6] - The company specializes in manufacturing core components for automotive engine power systems and has major clients including Changan Ford and Geely [6] Group 3 - Fund manager Xu Yan reduced holdings in Wufangzhai, with a current holding of 1.25 million shares, down from 2.22 million shares previously [8] - Wufangzhai, founded in 1921, focuses on glutinous rice food products and has been diversifying into mooncakes and other food items [9] - The company faced a public relations crisis earlier this year, impacting consumer trust and leading to a decline in stock price [9]